Literature DB >> 7982931

Potent peptide inhibitors of stromelysin based on the prodomain region of matrix metalloproteinases.

N Fotouhi1, A Lugo, M Visnick, L Lusch, R Walsky, J W Coffey, A C Hanglow.   

Abstract

Stromelysin is secreted as an inactive zymogen that is activated in the extracellular space by cleavage of the His81-Phe82 bond with the release of the 81-amino acid propeptide domain. This segment contains a 12-amino acid sequence (MRKPRC75GVPDVG) that is highly conserved in all matrix metalloproteinases. Previous studies have shown that the hexapeptide, Ac-RCGVPD-NH2, and the pentapeptide, Ac-RCGVP-NH2, based on this region retain significant inhibitory activity. This new structure-activity relationship study of both peptides has shown that only Cys75 and Val77 are essential for inhibitory activity. Peptides based on this series inhibited stromelysin and collagenase with equal potency. Additional peptides spanning this region were synthesized in order to focus on these two sites. Significantly, isocysteine was substituted for Cys75 without significant loss of inhibitory activity. Tyr-(2,6-dichlorobenzyl) was substituted for Val77. The introduction of these 2 new residues into Ac-CGVP-NH2 produced a very potent inhibitor, Ac-isoCGY-(2,6 dichlorobenzyl)-P-NH2 with an IC50 of 3 microM. The following factors, acting in combination, determine the inhibitory activity of peptides in this series: distance between the sulfur atom and the peptide backbone, coordination geometry of the thiol side chain with the active-site zinc, and conformational flexibility of the side-chain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.

Authors:  G Ferry; J A Boutin; G Atassi; J L Fauchère; G C Tucker
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

2.  A novel mechanism of latency in matrix metalloproteinases.

Authors:  Mar López-Pelegrín; Miroslaw Ksiazek; Abdulkarim Y Karim; Tibisay Guevara; Joan L Arolas; Jan Potempa; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

3.  Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase.

Authors:  Vladislav S Golubkov; Piotr Cieplak; Alexei V Chekanov; Boris I Ratnikov; Alexander E Aleshin; Natalya V Golubkova; Tatiana I Postnova; Ilian A Radichev; Dmitri V Rozanov; Wenhong Zhu; Khatereh Motamedchaboki; Alex Y Strongin
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

4.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

5.  The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.

Authors:  Ana Luísa Correia; Hidetoshi Mori; Emily I Chen; Fernando C Schmitt; Mina J Bissell
Journal:  Genes Dev       Date:  2013-04-01       Impact factor: 11.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.